Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 169,687,222
  • Shares Outstanding, K 1,550,221
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • 60-Month Beta N/A
  • Price/Sales 4.64
  • Price/Cash Flow 20.55
  • Price/Book 5.39
Trade AZN.LN with:
  • Price/Earnings ttm 35.73
  • Earnings Per Share ttm 3.81
  • Most Recent Earnings $0.62 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 2.88 (2.08%)
  • Most Recent Dividend 1.560 on 02/22/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10,154.000 +6.57%
on 03/20/24
11,184.021 -3.24%
on 04/12/24
+593.572 (+5.80%)
since 03/19/24
3-Month
9,461.000 +14.38%
on 02/12/24
11,184.021 -3.24%
on 04/12/24
+313.572 (+2.98%)
since 01/19/24
52-Week
9,461.000 +14.38%
on 02/12/24
12,348.000 -12.36%
on 04/25/23
-1,170.428 (-9.76%)
since 04/19/23

Most Recent Stories

More News
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

SMCI : 713.65 (-23.14%)
IP : 35.37 (+0.31%)
CRNX : 42.97 (-0.09%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
FUSN : 21.26 (+0.05%)
FCX : 49.61 (-1.10%)
UL : 47.31 (+0.98%)
ULVR.LN : 3,811.000 (+1.09%)
Stocks Slip Before the Open as Investors Await Earnings Reports, Disney Climbs on Strong Results

March S&P 500 E-Mini futures (ESH24) are down -0.18%, and March Nasdaq 100 E-Mini futures (NQH24) are down -0.16% this morning as market participants braced for the next round of quarterly results.

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
DIS : 112.61 (+0.16%)
EMR : 108.58 (-0.67%)
CMG : 2,869.11 (-1.34%)
F : 12.14 (+0.66%)
VFC : 12.83 (+1.26%)
SNAP : 11.16 (-4.04%)
COP : 129.38 (+1.23%)
PM : 93.77 (+2.82%)
DUK : 98.24 (+2.41%)
EXPE : 129.00 (+0.55%)
Stock market today: Asian shares are mixed ahead of the Fed's decision on interest rates

Asian shares are mixed after Wall Street rose to its highest level since early 2022, slightly below its record high, after a report showed inflation in the United States is behaving pretty much as expected...

M : 18.53 (-2.68%)
GOOGL : 154.09 (-1.23%)
ADBE : 465.02 (-1.72%)
HAS : 55.27 (+0.60%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
$SPX : 4,967.23 (-0.88%)
$DOWI : 37,986.40 (+0.56%)
$IUXX : 17,037.65 (-2.05%)
ORCL : 114.88 (-0.97%)
NVDA : 762.00 (-10.00%)
FB : 196.64 (+0.51%)
Oracle, Hasbro fall; Icosavax, Perion Network rise, Tuesday, 12/12/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Oracle, Hasbro fall; Icosavax, Perion Network rise

CHH : 116.35 (-0.62%)
PFE : 26.00 (+2.40%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
ORCL : 114.88 (-0.97%)
HAS : 55.27 (+0.60%)
3 stocks that crushed earnings estimates and still tanked

Every earnings season, regardless of sector or industry, has its share of stocks that go down even after beating earnings expectations such as these stocks

AZN : 68.55 (+0.28%)
SGHC : 3.10 (+1.64%)
WIX : 121.41 (-0.30%)
INTU : 605.17 (-0.53%)
AZN.LN : 10,821.572 (-0.85%)
AZNCF : 136.2000 (-1.48%)
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

President Joe Biden is touting his administration's efforts to lower medical costs

NVS : 94.36 (+1.93%)
MKKGY : 31.0900 (+0.06%)
PFE : 26.00 (+2.40%)
JNJ : 147.91 (+1.49%)
AMGN : 268.93 (+2.35%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
BMY : 48.93 (+1.30%)
Babies should get recently approved drug for RSV, CDC says

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

PFE : 26.00 (+2.40%)
GSK.LN : 1,598.936 (+0.97%)
GSK : 39.75 (+1.22%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
7 Best Cancer Stocks to Invest in Now

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

EXEL : 22.52 (+0.13%)
GILD : 66.76 (+0.91%)
NVS : 94.36 (+1.93%)
ON : 60.71 (-3.53%)
PFE : 26.00 (+2.40%)
MDCO : 84.90 (-0.07%)
MRK : 125.78 (+0.44%)
KURA : 17.53 (-0.85%)
AZN.LN : 10,821.572 (-0.85%)
BGNE : 129.52 (-1.85%)
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

PFE : 26.00 (+2.40%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
Tesla, Rivian rise; Apple, AstraZeneca fall, Monday, 7/3/2023

Stocks that traded heavily or had substantial price changes Monday: Tesla, Rivian rise; Apple, AstraZeneca fall

AAPL : 165.00 (-1.22%)
AZN.LN : 10,821.572 (-0.85%)
AZN : 68.55 (+0.28%)
GS : 404.00 (+0.22%)
FIS : 70.73 (+1.04%)
NFLX : 555.04 (-9.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 11,119.047
2nd Resistance Point 11,036.522
1st Resistance Point 10,929.048
Last Price 10,821.572
1st Support Level 10,739.049
2nd Support Level 10,656.524
3rd Support Level 10,549.050

See More

52-Week High 12,348.000
Fibonacci 61.8% 11,245.166
Fibonacci 50% 10,904.500
Last Price 10,821.572
Fibonacci 38.2% 10,563.834
52-Week Low 9,461.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar